Single-dose and steady-state pharmacokinetics of celecoxib in children

Clinical Pharmacology and Therapeutics

Volumn 72, Issue 5, 2002, Pages 490-497

  Stempak, Diana ^a   Gammon, Janet ^a   Klein, Julia ^a   Koren, Gideon ^a   Baruchel, Sylvain ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; VINBLASTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; ASTROCYTOMA; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG HALF LIFE; EPENDYMOMA; EWING SARCOMA; FEMALE; HEPATOBLASTOMA; HUMAN; MALE; MULTICENTER STUDY; NEUROBLASTOMA; OSTEOSARCOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SINGLE DRUG DOSE; STEADY STATE;

ADOLESCENT; AGE FACTORS; CHILD; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; MALE; PYRAZOLES; SULFONAMIDES;

EID: 0036880645     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2002.129322     Document Type: Article

References (22)

1. Paulson SK, Zhang JY, Jessen SM, Lawal Y, Liu NW, Dudkowski CM, et al. Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey. Xenobiotica 2000;30:731-44.
2. Vane J. Towards a better aspirin. Nature 1994;367:215-6.
3. van Ryn J, Pairet M. Clinical experience with cyclooxygenase-2 inhibitors. Inflamm Res 1999;48:247-54.
4. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta 1996;1299:125-40.
5. Masferrer JL, Isakson PC, Seibert K. Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract. Gastroenterol Clin North Am 1996;25:363-72.
6. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem 1986;55:69-102.
7. Levy GN. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J 1997;11:234-47
8. Masferrer JL, Koki A, Seibert K. COX-2 inhibitors. A new class of antiangiogenic agents. Ann N Y Acad Sci 1999;889:84-6
9. Form DM, Auerbach R. PGE2 and angiogenesis. Proc Soc Exp Biol Med 1983;172:214-8.
10. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
11. Paulson SK, Zhang JY, Breau AP, Hribar JD, Liu NW, Jessen SM, et al. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats. Drug Metab Dispos 2000;28:514-21.
12. Paulson SK, Vaughn MB, Jessen SM, Lawal Y, Gresk CJ, Yan B, et al. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. J Pharmacol Exp Ther 2001;297:638-45.
13. Food and Drug Administration. New drug application No. 20-998. Clinical pharmacology and biopharmaceutics review(s) - Celecoxib. Rockville (MD): Food and Drug Administration; 1998.
14. Kauffman RE. Drug therapeutics in the infant and child. In: Yaffe SJ, Aranda JV, editors. Pediatric pharmacology: therapeutic principles in practice. Philadelphia: W.B. Saunders; 1992. p. 212-9.
15. Rodman JH. Pharmacokinetic variability in the adolescent: implications of body size and organ function for dosage regimen design. J Adolesc Health 1994;15:654-62.
16. MacLeod SM. Clinical pharmacokinetics: a pediatric overview. In: MacLeod SM, Radde IC, editors. Textbook of pediatric clinical pharmacology. Littleton (MA): PSG; 1985. p. 106-10.
17. Kearns GL, Reed MD. Clinical pharmacokinetics in infants and children. A reappraisal. Clin Pharmacokinet 1989;17(Suppl 1):29-67.
18. Boreus LO. Pharmacokinetics in children. In: Azarnoff DL, editor. Principles of pediatric pharmacology. New York: Churchill Livingstone; 1982. p. 135-75.
19. Tang C, Shou M, Mei Q, Rushmore TH, Rodrigues AD. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor. J Pharmacol Exp Ther 2000;293:453-9.
20. Blanco JG, Harrison PL, Evans WE, Relling MV. Human cytochrome P450 maximal activities in pediatric versus adult liver. Drug Metab Dispos 2000;28:379-82.
21. Human P450 Metabolism Database. Available from: URL: http://www.gentest.com/human_p450_database/index.html. Accessed February 1, 2001.
22. Cummins R, Wagner-Weiner L, Paller A. Pseudoporphyria induced by celecoxib in a patient with juvenile rheumatoid arthritis. J Rheumatol 2000;27:2938-40.